Citi Reaffirms Their Buy Rating on China Medical System Holdings (CHSYF)Tip Ranks·Aug 19 at 07:25 PM00867+2.45%8A8-4.57%
Earnings Report: China Medical System Holdings Limited Missed Revenue Estimates By 5.0%Simplywall·Aug 19 at 06:42 PM00867+2.45%8A8-4.57%
G Sachs: CMS 1H26 Revenue Growth Slows but Earnings Resilience Strong; TP Cut to HKD17.96, Rated BuyAASTOCKS News·Aug 19 at 12:21 AM00867+2.45%8A8-4.57%
China Medical System (SEHK:867) Stock Revenue Push Meets Persistent Earnings StrainSimplywall·Aug 18 at 06:33 AM00867+2.45%8A8-4.57%
China Medical System Revises Interim Dividend for First Half of 2026Tip Ranks·Aug 17 at 11:39 PM00867+2.45%
China Medical System H1 FY26 profit rises 4.3% to RMB 971.5 million; revenue climbs 12.5% to RMB 4.5 billionPUBT·Aug 17 at 08:23 AM00867+2.45%8A8-4.57%
China Medical System schedules board meeting to review interim results, weigh dividendPUBT·Aug 5 at 04:56 AM00867+2.45%8A8-4.57%
INSILICO Jumps Up 5% after Nailing CNS Drug R&D Partnership with CMSAASTOCKS News·Jul 12 at 09:45 PM03696+14.60%8A8-4.57%
Insilico Medicine Deepens CNS Drug Development Tie-Up With China Medical SystemTip Ranks·Jul 12 at 07:08 PM03696+14.60%00867+2.45%
China Medical System Holdings (CHSYF) Gets a Buy from China RenaissanceTip Ranks·Jun 30 at 12:15 AM00867+2.45%8A8-4.57%
China Medical System files board, board committee and management disclosure rosterPUBT·Jun 29 at 06:38 AM00867+2.45%8A8-4.57%
China Renaissance Sticks to Their Buy Rating for China Medical System Holdings (CHSYF)Tip Ranks·Jun 26 at 08:45 PM00867+2.45%8A8-4.57%
China Medical System says China approves rabies antibody drug Silevimig InjectionPUBT·Jun 22 at 04:31 AM8A8-4.57%00867+2.45%
China Medical System files HKEX next-day disclosure return reporting share repurchasePUBT·Jun 17 at 07:09 AM00867+2.45%8A8-4.57%
CMS announced the preclinical research results of its self-developed small nucleic acid drug CMS-D008 at the ADA conference同壁财经·Jun 8 at 05:30 AM8A8-4.57%00867+2.45%
